-
AAPP 2025 Schedule
Enjoy browsing through all that the AAPP 2025 Annual Meeting has to offer!
Customize your schedule by bookmarking sessions of interest using the bookmark () buttons. Then, click the button below to only show your bookmarks.
Sunday, April 27, 2025
-
Pre-Meeting Workshop - Cultivating Expertise: Enhancing Presentation Design and Speaker Development in Psychiatric Pharmacists
ACPE
Megan Ehret, PharmD, MS, BCPP; Workshop Program Chair; Courtney Iuppa, PharmD, BCPP, Workshop Facilitator; J. Michael McGuire, PharmD, BCPP; Workshop Facilitator; Sarah T. Thomason, PharmD, BCPP, BCACP; Workshop Facilitator; Kara Wong, PharmD, BCPP; Workshop Facilitator
ACPE #: 0284-0000-25-001-L99-P (Application) (4.00 hours)
Aspen-L2
-
-
-
-
-
-
Industry Showcase
Schizophrenia Pathophysiology and Treatment Strategies
Supported by Bristol Myers Squibb Free Public Registration
Schizophrenia Pathophysiology and Treatment Strategies
Supported by Bristol Myers Squibb Free Public Registration
Austin Campbell, PharmD, BCPP, FAAPP
Salt Lake CD-L2
-
Networking! Hosted by the Program Committee and Recertification Editorial Board
Psych Spark Lounge-L4
-
-
Digital Therapeutics: ‘Cause We Are Living in a Digital World
ACPE
Timothy Aungst, PharmD
ACPE #: 0284-0000-25-002-L01-P (Knowledge) (1.00 hour)
Regency-L4
-
Difficult to Treat Depression – Emerging Strategies
ACPE
BCPP
Ilse Wiechers, MD, MPP, MHS
ACPE #: 0284-0000-25-003-L01-P (Application) (1.00 hour)
Regency-L4
-
-
-
-
Management of Tardive Dyskinesia with Vesicular Monoamine Transporter Type 2 (VMAT2) Inhibitors
ACPE
BCPP
Kayla Johnson, PharmD, BCPS, BCPP
ACPE #: 0284-0000-25-004-L01-P (Application) (1.00 hour)
Regency-L4
-
-
-
Monday, April 28, 2025
-
-
-
-
Industry Symposium
Names Will Never Hurt Me? “Antipsychotics” in the Treatment of Mood Disorders
Supported by Intra-Cellular Therapies ACPE Free Public Registration
Names Will Never Hurt Me? “Antipsychotics” in the Treatment of Mood Disorders
Supported by Intra-Cellular Therapies ACPE Free Public Registration
Joseph F. Goldberg, MD
Salt Lake CD-L2
-
-
-
From Inflammation to Treatment: Understanding Autoimmune Encephalitis
ACPE
Genalynne Mooneyham, MD, MS
ACPE #: 0284-0000-25-005-L01-P (Knowledge) (1.25 hours)
Regency-L4
-
-
Postpartum Psychosis: Etiology, Diagnosis, and Treatment
ACPE
Lauren M. Osborne, MD
ACPE #: 0284-0000-25-006-L01-P (Knowledge) (1.25 hours)
Regency-L4
-
-
Industry Symposium
Sniffing Out the Truth: Strategies for the Effective Recognition and Management When A “Whiff of Mania” is Present in Patients With Depression
Supported by Intra-Cellular Therapies ACPE Free Public Registration
Sniffing Out the Truth: Strategies for the Effective Recognition and Management When A “Whiff of Mania” is Present in Patients With Depression
Supported by Intra-Cellular Therapies ACPE Free Public Registration
Joseph F. Goldberg, MD
Salt Lake CD-L2
-
-
Interprofessional Care Coordination: Crossroads Between the Heart and Mind
ACPE
BCPP
David Parra, PharmD, BCPS, FCCP, FAHA
ACPE #: 0284-0000-25-008-L01-P (Application) (1.00 hour)
Regency AB-L4
-
-
-
Ketogenic Diet: A New Frontier in Psychiatry?
ACPE
Deanna Kelly, PharmD, BCPP
ACPE #: 0284-0000-25-007-L01-P (Knowledge) (1.00 hour)
Regency C-L4
-
-
Little Minds, Big Worries: Navigating Pediatric Anxiety
ACPE
Melissa Reyes, PharmD, BCPP
ACPE #: 0284-0000-25-009-L01-P (Knowledge) (1.00 hour)
Regency C-L4
-
Out With the Old and In With the New: Removal of the X-Waiver and the Role of the Psychiatric Pharmacist
ACPE
BCPP
Michelle Geier, PharmD, BCPP, APh, FAAPP; Damian Peterson, PharmD, BCPP, BCPS, APh
ACPE #: 0284-0000-25-010-L04-P (Application) (1.00 hour)
Regency AB-L4
-
-
-
Mood Stabilizer Management in Renal and Hepatic Disease: A Balancing Act
ACPE
Shadi Doroudgar, PharmD, APh, BCPS, BCGP, BCPP
ACPE #: 0284-0000-25-011-L01-P (Knowledge) (1.00 hour)
Regency C-L4
-
OCD- New and Emerging Therapies and the Role of Glutamatergic Medications
ACPE
BCPP
Robert Hudak, MD
ACPE #: 0284-0000-25-012-L01-P (Application) (1.00 hour)
Regency AB-L4
-
-
Industry Showcase
Clozapine RE(MS)defined: Enhancing Psychiatric Pharmacy Practice with Therapeutic Drug Monitoring and Updated Guidelines
Supported by Saladax Biomedical Free Public Registration
Clozapine RE(MS)defined: Enhancing Psychiatric Pharmacy Practice with Therapeutic Drug Monitoring and Updated Guidelines
Supported by Saladax Biomedical Free Public Registration
Megan Ehret, PharmD, MS, BCPP, FAAPP; Deanna L. Kelly, PharmD, BCPP; Robert O. Cotes, MD, DFAPA
Salt Lake CD-L2
-
Tuesday, April 29, 2025
-
-
-
-
-
Industry Showcase
Learn About COBENFY (xanomeline and trospium chloride): Where Does It Fit in Your Practice?
Supported by Bristol Myers Squibb Free Public Registration
Learn About COBENFY (xanomeline and trospium chloride): Where Does It Fit in Your Practice?
Supported by Bristol Myers Squibb Free Public Registration
Alberto Augsten, PharmD, MS, BCPP, DABAT
Salt Lake CD-L2
-
-
-
Gut Instincts: Disorders of Gut-Brain Interaction and Implications in Psychiatric Care
ACPE
Brian J. Arizmendi, PhD, ABPP
ACPE #: 0284-0000-25-013-L01-P (Knowledge) (1.25 hours)
Regency-L4
-
-
Addressing Social Determinants of Health through Trauma-informed Care
ACPE
Marie A. Chisholm-Burns, PhD, PharmD, MBA, MPH, FCCP, FASHP, FAST, FACHE
ACPE #: 0284-0000-25-014-L04-P (Knowledge) (1.25 hours)
Regency-L4
-
-
Industry Showcase
TechTonic Shift: Prescription Digital Therapeutics and the Future of Psychiatric Pharmacy
Supported by Boehringer Ingelheim Free Public Registration
TechTonic Shift: Prescription Digital Therapeutics and the Future of Psychiatric Pharmacy
Supported by Boehringer Ingelheim Free Public Registration
Kari Franson, PharmD, PhD, BCPP; Lisa Marsch, PhD; Nathaniel Rickles, PharmD, PhD, BCPP
Salt Lake CD-L2
-
-
-
Role of Monoamine Oxidase Deficiency in Aggression
ACPE
Marco Bortolato, MD, PhD
ACPE #: 0284-0000-25-015-L01-P (Knowledge) (1.00 hour)
Regency AB-L4
-
Clinical Pearls 1
ACPE
Jaden Dickinson, PharmD, BCPP; Brianne Mosley, PharmD, BCPS, BCPP; Kimberly Ehrhard, PharmD, BCPP
ACPE #: 0284-0000-25-016-L01-P (Knowledge) (1.00 hour)
Regency C-L4
-
-
Hormonal Harmony: Balancing Endocrine and Psychiatric Health
ACPE
Andrew Novick, MD, PhD
ACPE #: 0284-0000-25-017-L01-P (Knowledge) (1.00 hour)
Regency AB-L4
-
-
Clinical Pearls 2
ACPE
Alissa Scalise, PharmD, BCPS, BCPP; Roisin Sabol, PharmD; Zoe Karavolis, PharmD, MPH, BCPP, CPH
ACPE #: 0284-0000-25-018-L01-P (Knowledge) (1.00 hour)
Regency C-L4
-
-
-
Early Diagnosis and Treatment of Neurocognitive Disorders in the Psychiatric Setting
ACPE
Ganesh Gopalakrishna, MD
ACPE #: 0284-0000-25-020-L01-P (Knowledge) (1.00 hour)
Regency C-L4
-
-
Real-World Impact & Practical Insights of New Psychotropic Medications
ACPE
Danielle Stutzman, PharmD, BCPP; Daniel McGraw, PharmD, BCPP; Frank Tillman III, PharmD, BCPS, BCPP
ACPE #: 0284-0000-25-019-L01-P (Knowledge) (1.00 hour)
Regency AB-L4
-
-
Wednesday, April 30, 2025
-
-
-
-
-
Reframing Substance Use Through Decriminalization
ACPE
Jeffrey Bratberg, PharmD
ACPE #: 0284-0000-25-021-L04-P (Knowledge) (1.00 hour)
Regency-L4
-
Screening and Management of Gambling Disorder: Clinical Considerations
ACPE
Heather A. Chapman, PhD, ICGCII, BACC
ACPE #: 0284-0000-25-022-L01-P (Knowledge) (1.00 hour)
Regency-L4
-
Psychiatric and Neurologic Medication Pipeline
ACPE
Stephen R. Saklad, PharmD, BCPP
ACPE #: 0284-0000-25-023-L01-P (Knowledge) (1.00 hour)
Regency-L4